飞沃科技 reported revenue of ¥1.33B for the period ended 2026-06-30, +13.9% year on year. Net income was ¥0.00B, a 0.2% net margin on a 14.7% gross margin. The largest revenue line is 紧固件 at 80% of the total. Free cash flow for the period was ¥-0.10B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.33B | +13.9% |
| Gross profit | ¥0.20B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.00B | -88.1% |
| Gross margin | 14.7% | Net margin 0.2% |
| Revenue Q/Q | +25.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 紧固件 | ¥1.06B | 79.8% |
| 零部件 | ¥0.18B | 13.2% |
| 其他(补充) | ¥0.09B | 6.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.13B | 85.3% |
| R&D | ¥0.04B | 2.7% |
| SG&A | ¥0.09B | 6.9% |
| Tax & other | ¥0.01B | 0.5% |
| Item | Amount |
|---|---|
| Total assets | ¥5.18B |
| Total liabilities | ¥3.74B |
| Shareholders' equity | ¥1.44B |
| Equity / assets | 27.7% |
| Operating cash flow | ¥-0.05B |
| Capital expenditure | ¥0.05B |
| Free cash flow | ¥-0.10B |
| Cash conversion (OCF / net income) | -3892% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
盛帮股份 ・ 五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies